Decompression of Lumbar Central Spinal Canal Stenosis Following Minimally Invasive Transforaminal Lumbar Interbody Fusion
- PMID: 33979102
- DOI: 10.1097/BSD.0000000000001192
Decompression of Lumbar Central Spinal Canal Stenosis Following Minimally Invasive Transforaminal Lumbar Interbody Fusion
Abstract
Study design: This was a retrospective clinical series.
Objective: The objective of this study was to evaluate radiologic changes in central spinal canal dimensions following minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) with placement of a static or an expandable interbody device.
Summary of background data: MIS-TLIF is used to treat lumbar degenerative diseases and low-grade spondylolisthesis. MIS-TLIF enables direct and indirect decompression of lumbar spinal stenosis, with patients experiencing relief from radiculopathy and neurogenic claudication. However, the effects of MIS-TLIF on the central spinal canal are not well-characterized.
Materials and methods: We identified patients who underwent MIS-TLIF for degenerative lumbar spondylolisthesis and concurrent moderate to severe spinal stenosis. We selected patients who had both preoperative and postoperative magnetic resonance imaging (MRI) and upright lateral radiographs of the lumbar spine. Measurements on axial T2-weighted MRI scans include anteroposterior and transverse dimensions of the dural sac and osseous spinal canal. Measurements on radiographs include disk height, neural foraminal height, segmental lordosis, and spondylolisthesis. We made pairwise comparisons between each of the central canal dimensions and lumbar sagittal segmental radiologic outcome measures relative to their corresponding preoperative values. Correlation coefficients were used to quantify the association between changes in lumbar sagittal segmental parameters relative to changes in radiologic outcomes of central canal dimensions. Statistical analysis was performed for "all patients" and further stratified by interbody device subgroups (static and expandable).
Results: Fifty-one patients (age 60.4 y, 68.6% female) who underwent MIS-TLIF at 55 levels (65.5% at L4-L5) were included in the analysis. Expandable interbody devices were used in 45/55 (81.8%) levels. Mean duration from surgery to postoperative MRI scan was 16.5 months (SD 11.9). MIS-TLIF was associated with significant improvements in dural sac dimensions (anteroposterior +0.31 cm, transverse +0.38 cm) and osseous spinal canal dimensions (anteroposterior +0.16 cm, transverse +0.32 cm). Sagittal lumbar segmental parameters of disk height (+0.56 cm), neural foraminal height (+0.35 cm), segmental lordosis (+4.26 degrees), and spondylolisthesis (-7.5%) were also improved following MIS-TLIF. We did not find meaningful associations between the changes in central canal dimensions relative to the corresponding changes in any of the sagittal lumbar segmental parameters. Stratified analysis by interbody device type (static and expandable) revealed similar within-group changes as in the overall cohort and minimal between-group differences.
Conclusions: MIS-TLIF is associated with radiologic decompression of neural foraminal and central spinal canal stenosis. The mechanism for neural foraminal and central canal decompression is likely driven by a combination of direct and indirect corrective techniques.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
W.Z.R.: is a consultant with Depuy/Synthes and Globus Spine and has received non–study-related research support from the Department of Defense, National Institutes of Health, Defense Advanced Research Projects Agency. I.G.D.: is a consultant with Medtronic and Stryker. D.J.: is an advisor for Kaia Health. V.C.: is a consultant with DePuy Synthes and Globus Medical and has received non–study-related research support from Medtronic. The remaining authors declare no conflict of interest.
Similar articles
-
Minimally invasive transforaminal lumbar interbody fusion with expandable versus static interbody devices: radiographic assessment of sagittal segmental and pelvic parameters.Neurosurg Focus. 2017 Aug;43(2):E10. doi: 10.3171/2017.5.FOCUS17197. Neurosurg Focus. 2017. PMID: 28760032
-
Transfacet Minimally Invasive Transforaminal Lumbar Interbody Fusion With an Expandable Interbody Device-Part II: Consecutive Case Series.Oper Neurosurg. 2020 Oct 15;19(5):518-529. doi: 10.1093/ons/opaa144. Oper Neurosurg. 2020. PMID: 32433773
-
Assessment of radiographic and clinical outcomes of an articulating expandable interbody cage in minimally invasive transforaminal lumbar interbody fusion for spondylolisthesis.Neurosurg Focus. 2018 Jan;44(1):E8. doi: 10.3171/2017.10.FOCUS17562. Neurosurg Focus. 2018. PMID: 29290133
-
Restoration of lumbar lordosis after minimally invasive transforaminal lumbar interbody fusion: a systematic review.Spine J. 2019 May;19(5):951-958. doi: 10.1016/j.spinee.2018.10.017. Epub 2018 Dec 6. Spine J. 2019. PMID: 30529420
-
Assessing the Difference in Clinical and Radiologic Outcomes Between Expandable Cage and Nonexpandable Cage Among Patients Undergoing Minimally Invasive Transforaminal Interbody Fusion: A Systematic Review and Meta-Analysis.World Neurosurg. 2019 Jul;127:596-606.e1. doi: 10.1016/j.wneu.2019.03.284. Epub 2019 Apr 5. World Neurosurg. 2019. PMID: 30954733
Cited by
-
Application and thinking of minimally invasive transforaminal lumbar interbody fusion in degenerative lumbar diseases.Ann Transl Med. 2022 Mar;10(6):272. doi: 10.21037/atm-22-401. Ann Transl Med. 2022. PMID: 35433926 Free PMC article.
-
Lumbar fusion efficacy with local bone grafting and platelet-rich plasma: a clinical investigation in treating degenerative lumbar spinal stenosis in the elderly.Int Orthop. 2024 Nov;48(11):2963-2970. doi: 10.1007/s00264-024-06294-2. Epub 2024 Sep 17. Int Orthop. 2024. PMID: 39287668
-
Efficacy of lumbar decompression under large-channel spinal endoscope in elderly patients with segmental lumbar spinal stenosis.J Orthop Surg Res. 2024 Jan 3;19(1):16. doi: 10.1186/s13018-023-04389-x. J Orthop Surg Res. 2024. PMID: 38167077 Free PMC article.
-
The efficacy and safety of tranexamic acid in transforaminal lumbar interbody fusion: a systematic review and meta-analysis.EFORT Open Rev. 2023 Dec 1;8(12):919-925. doi: 10.1530/EOR-23-0168. EFORT Open Rev. 2023. PMID: 38038372 Free PMC article.
-
Influence of rapid recovery nutritional support on functional recovery and hospitalization duration in patients undergoing minimally invasive lumbar surgery.Am J Transl Res. 2023 Dec 15;15(12):7023-7034. eCollection 2023. Am J Transl Res. 2023. PMID: 38186983 Free PMC article.
References
-
- Katz JN, Harris MB. Clinical practice. Lumbar spinal stenosis. N Engl J Med. 2008;358:818–825.
-
- Ghogawala Z, Dziura J, Butler WE, et al. Laminectomy plus fusion versus laminectomy alone for lumbar spondylolisthesis. N Engl J Med. 2016;374:1424–1434.
-
- Forsth P, Olafsson G, Carlsson T, et al. A randomized, controlled trial of fusion surgery for lumbar spinal stenosis. N Engl J Med. 2016;374:1413–1423.
-
- Yoon JW, Wang MY. The evolution of minimally invasive spine surgery: JNSPG 75th Anniversary Invited Review Article. J Neurosurg Spine. 2019;30:149–158.
-
- Yoshihara H. Indirect decompression in spinal surgery. J Clin Neurosci. 2017;44:63–68.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials